All In Biotech

Free tool

FAERS Monitor: Ephedrine Sulfate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208609 or its brand name (Ephedrine Sulfate, Ephedrine Sulfate). Reports on generic versions are filed under their own applications.

Reports

130

Serious

100

77% of reports

Hospitalization

40

Death reported

20

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective15
  • cardiac arrest13
  • toxicity to various agents13
  • drug abuse12
  • overdose12
  • respiratory arrest11
  • administration related reaction10
  • hypotension10
  • off label use10
  • drug hypersensitivity9
  • nausea8
  • pain8
  • anxiety7
  • asthenia7
  • back pain6

Reports by year received

View as table
YearReports
20064
20084
20092
20106
20112
20121
20131
20144
20151
20162
20175
201817
201913
202010
20216
20228
202316
202414
20254
202610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,029 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
administration related reactionSignal108754.34743.974,938
respiratory arrestSignal1164.636.7627
cardiac arrestSignal1325.515.2283
drug abuseSignal1223.313.6235
toxicity to various agentsSignal1312.57.4127
overdoseSignal129.05.378
hypotensionSignal108.14.456
drug hypersensitivitySignal97.54.045
back painSignal64.21.912
anxietySignal74.01.913
astheniaSignal73.01.58
pain82.11.14
off label use101.81.03
drug ineffective151.81.15
nausea81.60.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.